Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinod Metta

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Parkinson'S Disease|December 23, 2011
The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation projectVinod Metta, Kartik Logishetty, P Martinez-Martin, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 10, 2025
"Dozing off" in the car and excessive daytime sleepiness (EDS) in Parkinson's disease: a survey of 125 patientsCarolina Sportelli, Karolina Poplawska-Domaszewicz, Corinne Borley, et al.
European Journal of Neurology|February 9, 2023
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's diseaseValentina Leta, Lisa Klingelhoefer, Katherine Longardner, et al.
Scientific Reports|November 1, 2023
Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experienceVinod Metta, Rajinder K Dhamija, Lucia Batzu, et al.
Journal of Personalized Medicine|August 27, 2021
Personalised Advanced Therapies in Parkinson's Disease: The Role of Non-Motor Symptoms ProfileValentina Leta, Haidar S Dafsari, Anna Sauerbier, et al.
Frontiers in Neurology|June 12, 2023
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical testsMubasher A Qamar, Silvia Rota, Lucia Batzu, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 5, 2023
A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson's disease based in United Arab EmiratesVinod Metta, Huzaifa Ibrahim, Neha Muralidharan, et al.
Scientific Reports|November 21, 2024
The first cross-sectional comparative observational study of sexual dysfunction in Emirati and non-Emirati Parkinson's disease patients (EmPark-SD) in the United Arab EmiratesVinod Metta, Huzaifa Ibrahim, Mubasher A Qamar, et al.
Frontiers in Aging Neuroscience|June 17, 2026
Overcoming the diagnostic gap in mild cognitive impairment in Parkinson's disease: a pilot study employing a machine learning-/augmented reality-based digital biomarkerKarolina Poplawska-Domaszewicz, Emmanuel Streel, Aleksandra Brek, et al.
Journal of Personalized Medicine|August 26, 2022
First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson's Disease in Emiratis and Expatriate Population of United Arab Emirates 2019-2021: The EmPark StudyVinod Metta, Huzaifa Ibrahim, Tom Loney, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Parkinson'S Disease|December 23, 2011
The possible clinical predictors of fatigue in Parkinson's disease: a study of 135 patients as part of international nonmotor scale validation projectVinod Metta, Kartik Logishetty, P Martinez-Martin, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 10, 2025
"Dozing off" in the car and excessive daytime sleepiness (EDS) in Parkinson's disease: a survey of 125 patientsCarolina Sportelli, Karolina Poplawska-Domaszewicz, Corinne Borley, et al.
European Journal of Neurology|February 9, 2023
Gastrointestinal barriers to levodopa transport and absorption in Parkinson's diseaseValentina Leta, Lisa Klingelhoefer, Katherine Longardner, et al.
Scientific Reports|November 1, 2023
Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experienceVinod Metta, Rajinder K Dhamija, Lucia Batzu, et al.
Journal of Personalized Medicine|August 27, 2021
Personalised Advanced Therapies in Parkinson's Disease: The Role of Non-Motor Symptoms ProfileValentina Leta, Haidar S Dafsari, Anna Sauerbier, et al.
Frontiers in Neurology|June 12, 2023
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical testsMubasher A Qamar, Silvia Rota, Lucia Batzu, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 5, 2023
A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson's disease based in United Arab EmiratesVinod Metta, Huzaifa Ibrahim, Neha Muralidharan, et al.
Scientific Reports|November 21, 2024
The first cross-sectional comparative observational study of sexual dysfunction in Emirati and non-Emirati Parkinson's disease patients (EmPark-SD) in the United Arab EmiratesVinod Metta, Huzaifa Ibrahim, Mubasher A Qamar, et al.
Frontiers in Aging Neuroscience|June 17, 2026
Overcoming the diagnostic gap in mild cognitive impairment in Parkinson's disease: a pilot study employing a machine learning-/augmented reality-based digital biomarkerKarolina Poplawska-Domaszewicz, Emmanuel Streel, Aleksandra Brek, et al.
Journal of Personalized Medicine|August 26, 2022
First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson's Disease in Emiratis and Expatriate Population of United Arab Emirates 2019-2021: The EmPark StudyVinod Metta, Huzaifa Ibrahim, Tom Loney, et al.
Pageof 4